Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDK | P21741 | 5/20 | 0.51 |
| ▸ | BDNF | P23560 | 3/20 | 0.51 |
| ▸ | PTN | P21246 | 2/20 | 0.51 |
| ▸ | F10 | P00742 | 2/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.40 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.40 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.40 |
| ▸ | CXCL10 | P02778 | 1/20 | 0.36 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.36 |
| ▸ | CCL2 | P13500 | 1/20 | 0.36 |
| ▸ | CCL5 | P13501 | 1/20 | 0.36 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.36 |
| ▸ | CD69 | Q07108 | 1/20 | 0.36 |
| ▸ | FGF2 | P09038 | 1/20 | 0.35 |
| ▸ | F9 | P00740 | 2/20 | 0.35 |
| ▸ | F8 | P00451 | 1/20 | 0.35 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.35 |
| ▸ | FGF1 | P05230 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19852803 | 0.89 | LGALS3 (0.45) | MDKBDNFPTNLGALS3LGALS8 | |
| SCHEMBL25645148 | 0.88 | LGALS3 (0.51) | MDKBDNFPTNLGALS3LGALS8 | |
| Dermatan Sulfate SCHEMBL25645152 | 0.87 | MDK (0.54) | MDKBDNFPTNF10LGALS3 | |
| Dermatan Sulfate SCHEMBL15144387 | 0.87 | MDK (0.54) | MDKBDNFPTNF10LGALS3 | |
| Dermatan Sulfate SCHEMBL10157447 | 0.87 | MDK (0.54) | MDKBDNFPTNF10LGALS3 | |
| SCHEMBL13321878 | 0.84 | MDK (0.61) | MDKBDNFPTNF10LGALS3 | |
| SCHEMBL29371806 | 0.84 | MDK (0.61) | MDKBDNFPTNF10LGALS3 | |
| SCHEMBL29908269 | 0.83 | MDK (0.54) | MDKBDNFPTNF10LGALS3 | |
| SCHEMBL13431404 | 0.83 | MDK (0.60) | MDKBDNFPTNF10LGALS3 | |
| SCHEMBL25645147 | 0.82 | F10 (0.50) | MDKBDNFPTNF10LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030963-B2 | Matrices comprising a modified polysaccharide | MAPTECH HOLDINGS UG (DE) | 2024-07-09 | — | — | US | disclosed |
| US-20210355247-A1 | MATRICES COMPRISING A MODIFIED POLYSACCHARIDE | ALBERT-LUDWIGS UNIVERSITÄT FREIBURG (DE) | 2021-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210355247-A1 | MATRICES COMPRISING A MODIFIED POLYSACCHARIDE | FUT5, FUT6, CSGALNACT1 | MDK 2681/4885BDNF 2039/4885PTN 225/4885 |
| US-12030963-B2 | Matrices comprising a modified polysaccharide | FUT5, FUT6, CSGALNACT1 | MDK 2681/4885BDNF 2039/4885PTN 225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.